Disease modification in axial spondyloarthritis

被引：11
作者：
Sari, Ismail [1 ,2 ]
Haroon, Nigil [2 ,3 ]
机构：
[1] Dokuz Eylul Univ, Sch Med, Dept Rheumatol, Izmir, Turkey
[2] Univ Toronto, Toronto Western Hosp, Div Rheumatol, Toronto, ON, Canada
[3] Univ Toronto, Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada
来源：
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2018年 / 32卷 / 03期
关键词：
Spondylarthropathies; Ankylosing spondylitis; Disease progression; Outcomes assessment; Tumor necrosis factor-alpha; Non-steroidal anti-inflammatory agents; Smoking; Diagnostic imaging; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SPINAL RADIOGRAPHIC PROGRESSION; BONE MORPHOGENETIC PROTEINS; TUMOR-NECROSIS-FACTOR; ANKYLOSING-SPONDYLITIS; STRUCTURAL DAMAGE; INFLAMMATION; EFFICACY; SECUKINUMAB; ENTHESITIS;
D O I：
10.1016/j.berh.2019.02.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The concept of "disease modification" refers to an intervention that modifies the natural clinical course of the disease along with improvement of symptoms. With regard to this, providing treatment that improves clinical signs and symptoms of axial spondyloarthritis (axSpA) and that impacts disease pathogenesis by slowing/halting bone formation is the main goal of this concept. It has been proven that currently available treatments including biologics and nonsteroidal anti-inflammatory drugs have a symptom-modifying effect in axSpA. The body of evidence showing a beneficial effect of biologic therapy on spinal damage is growing. In this article, by centralizing new bone formation as a main target of disease modification, we reviewed molecular mechanisms related to new bone formation, relevance of imaging studies on assessment of disease progression, clinical predictors of new bone formation, and disease-modifying properties of currently available treatments in axSpA. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码：427 / 439
页数：13
相关论文
共 88 条
  • [1] Molecular mechanisms of bone formation in spondyloarthritis
    Aidee Gonzalez-Chavez, Susana
    Maria Quinonez-Flores, Celia
    Pacheco-Tena, Cesar
    [J]. JOINT BONE SPINE, 2016, 83 (04) : 394 - 400
  • [2] Altered Skeletal Expression of Sclerostin and Its Link to Radiographic Progression in Ankylosing Spondylitis
    Appel, Heiner
    Ruiz-Heiland, Gisela
    Listing, Joachim
    Zwerina, Jochen
    Herrmann, Martin
    Mueller, Ruediger
    Haibel, Hildrun
    Baraliakos, Xenofon
    Hempfing, Axel
    Rudwaleit, Martin
    Sieper, Joachim
    Schett, Georg
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3257 - 3262
  • [3] Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor a antibody infliximab
    Baraliakos, X
    Listing, J
    Rudwaleit, M
    Brandt, J
    Sieper, J
    Braun, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) : 1462 - 1466
  • [4] SECUKINUMAB DEMONSTRATES LOW RADIOGRAPHIC PROGRESSION AND SUSTAINED EFFICACY THROUGH 4 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS
    Baraliakos, X.
    Braun, J.
    Deodhar, A.
    Poddubny, D.
    Emery, P.
    Delicha, E. M.
    Talloczy, Z.
    Porter, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 997 - 998
  • [5] Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography
    Baraliakos, X.
    Heldmann, F.
    Callhoff, J.
    Listing, J.
    Appelboom, T.
    Brandt, J.
    Van den Bosch, F.
    Breban, M.
    Burmester, G. R.
    Dougados, M.
    Emery, P.
    Gaston, H.
    Grunke, M.
    Van Der Horst-Bruinsma, I. E.
    Landewe, R.
    Leirisalo-Repo, M.
    Sieper, J.
    De Vlam, K.
    Pappas, D.
    Kiltz, U.
    Van Der Heijde, D.
    Braun, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (10) : 1819 - 1825
  • [6] Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study
    Baraliakos, Xenofon
    Borah, Babul
    Braun, Juergen
    Baeten, Dominique
    Laurent, Didier
    Sieper, Joachim
    Emery, Paul
    McInnes, Iain B.
    van Laar, Jacob M.
    Wordsworth, Paul
    Wollenhaupt, Juergen
    Kellner, Herbert
    Colin, Laurence
    Vandenhende, Francois
    Radford, Kath
    Hueber, Wolfgang
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (02) : 408 - 412
  • [7] Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
    Baraliakos, Xenofon
    Haibel, Hildrun
    Listing, Joachim
    Sieper, Joachim
    Braun, Juergen
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : 710 - 715
  • [8] The Natural Course of Radiographic Progression in Ankylosing Spondylitis: Differences Between Genders and Appearance of Characteristic Radiographic Features
    Baraliakos, Xenofon
    Listing, Joachim
    von der Recke, Anna
    Braun, Juergen
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (05) : 383 - 387
  • [9] The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients
    Baraliakos, Xenofon
    Listing, Joachim
    von der Recke, Anna
    Braun, Jurgen
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (05) : 997 - 1002
  • [10] Clinical and Imaging Efficacy of Infliximab in HLA-B27-Positive Patients With Magnetic Resonance Imaging-Determined Early Sacroiliitis
    Barkham, Nick
    Keen, Helen I.
    Coates, Laura C.
    O'Connor, Philip
    Hensor, Elizabeth
    Fraser, Alexander D.
    Cawkwell, Lorna S.
    Bennett, Alexander
    McGonagle, Dennis
    Emery, Paul
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (04): : 946 - 954
123456789